Navigation Links
Is There A Strong Link Between Fluoride In Tap Water And Bone Cancer?

In the previous studies it was brought to the public’s notice that fluoride in water causes discolored teeth. It causes fluorosis and does not protect// the teeth from cavities. But now Dr. Chester Douglass and other Harvard researchers reported that fluoridated tap water pose a great risk of boys developing for a rare bone cancer. Douglass is an epidemiology professor at Harvard’s School of Dental Medicine.

He is paid to work as an editor of the Colgate Oral Care Report, a newsletter supported by the toothpaste maker. The results of the study were published online in a Harvard-affiliated journal. This could intensify debate over fluoridation. Richard Wiles of the Environmental Working Group filed a complaint with the National Institutes of Health (NIH) against Douglass. Now Harvard and the NIH are jointly investigating the work of Douglass.

This is because last year he reported from his research findings that there was no link between fluoride and cancer, despite extensive research to the contrary by one of his doctoral students. The NIH gave Douglass at least $1 million for the research. Dr. Elise Bassin, who is the doctoral student published in a journal Cancer Causes and Control that boys who drink water with levels of fluoride considered safe by federal guidelines are five times more likely to develop osteosarcoma than boys who drink unfluoridated water.

Statistics show that every year about 250 boys are diagnosed with osteosarcoma, the most common type of bone cancer and the sixth most common cancer in children in US. But he also adds that more research is needed to confirm or refute this observation.


Page: 1

Related medicine news :

1. Could There Be A Link Between Famine and Breast Cancer ?
2. Can There Be A Diabetes Type III?
3. Diabetic Amputation May Reduce If Free Screenings Are There
4. Hospital Says There Is Time but Baby Decides Otherwise
5. WHO’s asking :Is There Light At The End Of The Tunnel In Tajikistan
6. There is light at the end of the blind tunnel: prosthetic retinal cells offer hope!
7. Is There a Connection between Hearing loss and High-speed Dental Tools?
8. Is There Any Clinical Benefit to Staying on a Failing Regimen?
9. Strong pain killers likely to cause miscarriage
10. Stronger Backing for Drug-Coated Stents
11. ‘Protein’ Produced By Overstressed Heart Muscle a Strong Indicator Of Heart Diseae
Post Your Comments:

(Date:12/1/2015)... ... December 01, 2015 , ... ... of adjunctive imaging is the focus of numerous abstracts accepted for presentation here, ... 4, 2015. Nine abstracts highlight the use of Volpara Solutions’ quantitative breast ...
(Date:12/1/2015)... ... December 01, 2015 , ... SAN FRANCISCO, Calif. (December 1, ... organization has awarded Education and Developmental Therapies (EDT), an Applied Behavior Analysis (ABA) ... exceptional special needs providers that excel in synthesizing the areas of clinical quality, ...
(Date:12/1/2015)... ... 2015 , ... TCS Healthcare Technologies (TCS), a leading provider ... is pleased to announce that VIP Care Services, a Caprock Health Group affiliate ... Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY Complete ...
(Date:12/1/2015)... ... 01, 2015 , ... With FCPX Overlay: Grit , users can apply ... the possibilities are truly endless, all with a click of a mouse. Each user ... horizontal flip, depth of field and more, all within Final Cut Pro X. , ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... Contact Center Enterprise Authorized Technology Provider (ATP) status from Cisco. This designation recognizes ... and support Cisco Unified Contact Center solutions targeted to the high-end enterprise contact ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 2015 Breg, Inc ., a premier ... that it has been awarded three contracts by Novation, ... Novation will have access to improved pricing for Breg,s ... soft goods dedicated to advancing orthopedic care.  ... U.S. population, rising prevalence of chronic conditions and the ...
(Date:12/1/2015)... Russia has always been a country of choice ... in Europe in 2015 were tested in phase ... has always been a country of choice for global multi-center ... Europe in 2015 were tested in phase II-III clinical ... has always been a country of choice for global multi-center phase III ...
(Date:12/1/2015)... CytRx Corporation (NASDAQ: CYTR ), a ... announced that it has reached its enrollment target of ... clinical trial of aldoxorubicin in patients with previously treated ... completed in Q1 2016. The Phase 3 trial is a ... Assessment from the FDA at 79 sites in ...
Breaking Medicine Technology: